Group 1 - The Hong Kong stock market opened lower on October 22, with the Hang Seng Index down 0.5% at 25,897.62 points, and the Hang Seng Tech Index down 0.82% [1] - The technology sector saw widespread declines, while innovative drug concepts opened higher, and Chinese brokerage stocks were active [1] - The outlook for Hong Kong stocks suggests that the pricing power of Chinese companies is strengthening, with liquidity remaining stable, and a focus on new catalysts in the pharmaceutical and e-commerce sectors [1][2] Group 2 - The Hang Seng Technology Index ETF (513180) is currently valued at a P/E ratio of 23.05, which is at the 30.12% valuation percentile since its inception, indicating that the current valuation is lower than approximately 70% of the time since the index was launched [2] - The innovative drug sector in Hong Kong has returned to a reasonable valuation range after previous adjustments, with expectations for potential excess returns driven by new catalysts [2] - The e-commerce sector is anticipated to benefit from the upcoming Double Eleven shopping festival, with promotional cycles extending across platforms [2]
港股三大指数集体低开,泡泡玛特涨近8%